HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy eraMaria João Baptista, José‐Tomás Navarro, Olga García et al.|AIDS|2015Cited by 50
Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)Ramón García‐Sánz, Carmen Martı́nez, Anna Sureda et al.|Blood|2016Cited by 47
HIV-infection has no prognostic impact on advanced-stage Hodgkin lymphomaMarc Sorigué, José‐Tomás Navarro, Olga García et al.|AIDS|2017Cited by 22
The long term follow-up of early stage follicular lymphoma treated with radiotherapy, chemotherapy or combined modality treatmentJuan‐Manuel Sancho, Josep‐María Ribera, Rubén Fernández-Álvarez et al.|Leukemia Research|2015Cited by 19
Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus–related LymphomasJosep Muncunill, José‐Tomás Navarro, Maria João Baptista et al.|Clinical Infectious Diseases|2018Cited by 16